<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We report 14 cases of secondary <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (sMDS) following treatment with <z:chebi fb="2" ids="2948">azathioprine</z:chebi> for non-malignant disorders </plain></SENT>
<SENT sid="1" pm="."><plain>Long-term treatment with <z:chebi fb="2" ids="2948">azathioprine</z:chebi> seems to be associated with an increased risk of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e> and subsequent leukemic transformation </plain></SENT>
</text></document>